Model Number FHC-A202 |
Device Problem
False Negative Result (1225)
|
Patient Problem
Insufficient Information (4580)
|
Event Type
malfunction
|
Manufacturer Narrative
|
Results pending completion of the investigation.
|
|
Event Description
|
It was reported that false negatives were occurring with no confirmatory information.Although requested, no further information has been provided.There was no adverse event nor injuries reported.
|
|
Manufacturer Narrative
|
D9: no.H3: not returned to the manufacturer.Investigation conclusion: retained devices from the reported lot number were tested with qc cut-off urine standards 20 miu/ml) and high-hcg clinical urine samples (212.0-215.6 iu/ml).The results were read at 3 minutes and all devices yielded the expected positive results.Retained devices were also tested with qc cut-off serum standards (10 miu/ml).The results were read at 5 minutes and all devices yielded the expected positive results.No false negative results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Manufacturing batch record review did not uncover any relevant non-conformances and found that the lot met quality control specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.A root cause could not be determined from the available information as the reported issue was not replicated during testing of retention product.Complaints are tracked and trended on a monthly basis.Per the package insert, false negative results may occur when the levels of hcg are below the sensitivity level of the test.Very dilute urine specimens, as indicated by a low specific gravity, may not contain representative levels of hcg.If pregnancy is still suspected, a first morning urine specimen should be collected 48 hours later and tested.This test provides a presumptive diagnosis for pregnancy.A confirmed diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
|
|
Manufacturer Narrative
|
D9: device available for evaluation.Yes.(b)(6) 2021.H3: yes.Investigation conclusion: retained and returned devices from the reported lot number were tested with qc cut-off urine standards (20 miu/ml) and high-hcg clinical urine samples (205.7-222.1 iu/ml).The results were read at 3 minutes and all devices yielded the expected positive results.Retained devices were also tested with qc cut-off serum standards (10 miu/ml).The results were read at 5 minutes and all devices yielded the expected positive results.No false negative results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Manufacturing batch record review did not uncover any relevant non-conformances and found that the lot met quality control specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.A root cause could not be determined from the available information as the reported issue was not replicated during testing of either retention or returned product.Complaints are tracked and trended on a monthly basis.Per the package insert, false negative results may occur when the levels of hcg are below the sensitivity level of the test.Very dilute urine specimens, as indicated by a low specific gravity, may not contain representative levels of hcg.If pregnancy is still suspected, a first morning urine specimen should be collected 48 hours later and tested.This test provides a presumptive diagnosis for pregnancy.A confirmed diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
|
|
Search Alerts/Recalls
|